HO, MENG-FEN,CHEN, SHU-PING,CHEN, YUNG-FA,HENSCHKE, JULIAN PAUL
申请号：
CA2852000
公开号：
CA2852000A1
申请日:
2012.10.30
申请国别(地区):
CA
年份:
2013
代理人:
摘要：
The present invention provides amorphous forms and the crystalline complexes of SGLT2 inhibitors as a novel material, in particular in pharmaceutically acceptable form. The crystalline forms of SGLT2 inhibitor canagliflozin are designated as Forms CS1, CS2, CS3, CS4 and CS5.
